Contents:
.102 mmol) in MeOH (1 mL) was added to the NHS-activated ester solution. The resulting suspension was stirred for 6 h at room temperature. After evaporation of the solvent, N-propanoyl, N-butanoyl and Nhexanoylglucosamine were isolated by silica gel column using a mixture AcOEt/MeOH/AcOH 2:1:1 as the eluent with 70%, 98% and 91% yield, respectively (NMR spectra and the corresponding annotation are shown in the Supplementary Fig. S8 -S10). The enzymatic reaction (25 µL) containing 100 mM of N-acylglucosamine derivative, 200 mM of Na 2 HPO 4 buffer (pH 8.0) and recombinant CmCBDA (0.013 U), were incubated for 6 h, and then quenched by adding 25 µL of chloroform. After centrifugation, an aliquot of the upper-phase was used for the determination of the produced GlcN after o-phtalaldehyde (OPA) derivatisation using the colorimetric assay in the article section 'Activity and substrate specificity screening'. Screening Results are shown in the Supplementary Figure S7 .
2) Alloc-, Boc-, Cbz-and Fmoc-protected glucosamines
Boc-and Cbz-protected glucosamine were purchased from commercial suppliers. Fmoc-and Alloc-protected glucosamine were synthetized. A solution of glucosamine hydrochloride (20 mg, 0.093 mmol), NaHCO 3 (14 mg, 0.186 mmol) and 9-fluorenylmethyl chloroformate or allyl chloroformate (0.140 mmol) in 1 mL H 2 O/Acetone 1:1 was stirred for 24 h at room temperature. After evaporation of the reaction solvent, the residue was washed several times with diethyl ether. Then, the residue was subjected to purification by silica-gel chromatography using a mixture AcOEt/MeOH 4:1 as the eluent obtaining the desired carbamate (Fmoc-protected glucosamine: 79%, Alloc-protected glucosamine: 72% yield). (NMR spectra and the corresponding annotation are shown in the Supplementary Fig. S11 -S12). Reaction mixtures (25 µL) containing 100 mM of N-protected glucosamine, 200 mM of Na 2 HPO 4 buffer (pH 8.0) and recombinant enzyme CmCBDA (0.013 U), were incubated for 6 h, and then quenched by adding 25 µL of chloroform. After centrifugation, an aliquot of the upper-phase was used for the determination of the produced GlcN after o-phtalaldehyde (OPA) derivatisation using the colorimetric assay in the article section 'Activity and substrate specificity screening'. Screening Results are shown in the Supplementary Figure S7 .
3) N-acetyl amino acids as CmCBDA substrates
N-acetyl amino acids of all proteinogenic amino acids were purchased from commercial suppliers. Reaction mixtures (25 µL) containing 100 mM of N-acetyl amino acids, 200 mM of Na 2 HPO 4 buffer (pH 8.0) and recombinant enzyme CmCBDA (0.013 U), were incubated for 6 h, and then quenched by adding 25 µL of chloroform. After centrifugation, an aliquot of the upper-phase was used for the determination of the produced GlcN after ophtalaldehyde (OPA) derivatisation using the colorimetric assay in the article section 'Activity and substrate specificity screening'. Screening Results are shown in the Supplementary Figure S7 . (q, 2H, J = 7.6 Hz); 2.23 (q, 2H, J = 7.6 Hz); 1.05 (t, 3H, J = 7.6 Hz), 1.05* (t, 3H, J = 7.6 Hz).
C NMR (100 MHz, D 2 O):
δ (duplicated signals are observed for some carbons; asterisks indicate those corresponding to the alpha anomer)
178. 66, 178.45*; 94.90, 90.82*; 75.88*, 73.78; 71.50*, 70.56; 70.02*, 69.80; 60.67, 60.51*; 56.49, 53.90*; 29.32, 29 .00*; 9.48*, 9.43. (t, 3H, J = 7.6Hz), 0.84* (t, 3H, J = 7.6Hz). analysed at a constant CmCBDA concentration of 1 mg/ml (in Panel A, Panel B had no CmCBDA added) in a 0.01 cm path length cuvette with different concentrations of GlcNAc ranging from 1 µM to 10 mM. Each sample was recorded 5 times repeat. Sodium phosphate buffer(0.1 M, pH 8.0) was analysed under the same condition and subtracted, which were subsequently averaged to obtain the final result. The secondary structure of protein with different concentrations of GlcNAc was analysed by using CDNN software (version 2.0.3.188) . No obvious changes in the secondary structure of CmCBDA were observed with increasing amounts of GlcNAc.
